NCT07153146View on ClinicalTrials.gov

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PN-881 in Healthy Subjects.

PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

142

Participants

Timeline

Start Date

September 8, 2025

Primary Completion Date

June 15, 2026

Study Completion Date

June 15, 2026

Conditions

Healthy Volunteer

Interventions

DRUG

PN-881 Oral Solution

PN-881 Oral Solution

DRUG

PN-881 Oral Tablet

PN-881 oral tablet

DRUG

Placebo

Placebo

Trial Locations (1)

3004

Nucleus Network, Melbourne

All Listed Sponsors

lead

Protagonist Therapeutics, Inc.

INDUSTRY